Advertisement

Proliferative Potential of Malignant and Non-Malignant Meningiomas

  • K. G. Cho
  • T. Hoshino
  • T. Nagashima
  • R. L. Davis
Chapter
  • 38 Downloads
Part of the Developments in Oncology book series (DION, volume 52)

Abstract

Meningiomas are common neoplasms in the central nervous system. Although most of these tumors are encapsulated and grow very slowly, some meningiomas invade into adjacent brain tissue and skull, grow faster, and recur more frequently than classic meningiomas. These malignant meningiomas, however, are not well defined histopathologically, and their biological characteristics have never been well documented. We studied the cell kinetics of human meningiomas immunohistochemically using a monoclonal antibody against bromodeoxyuridine (BUdR) (2), a thymidine analogue that is incorporated into nuclear DNA during the synthesis phase of the cell cycle. BUdR-labeled S-phase cells can be identified by anti-BUdR monoclonal antibodies, which can then be detected by indirect immunoperoxiase methods (3, 6).

Key words

Meningiomas Labeling Index BUdR 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cho (K.G.), Hoshino (T.), Nagashima (T.) et al.: The prediction of tumor doubling time in recurrent meningiomas: Cell kinetics studies with bromodeoxyuridine. J. Neurosurg. 65: 790–794, 1986.PubMedCrossRefGoogle Scholar
  2. 2.
    Gratzner (H.G.): Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218: 474–476, 1982.PubMedCrossRefGoogle Scholar
  3. 3.
    Hoshino (T.), Nagashima (T.), Murovic (J.) et al.: Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 6: 627–632, 1985.PubMedCrossRefGoogle Scholar
  4. 4.
    Hoshino (T.), Nagashima (T.), Murovic (J.A.), et al.: Proliferative potential of human meningiomas of brain: A cell kinetic study with bromodeoxyuridine. Cancer 58: 1466–1472, 1986.PubMedCrossRefGoogle Scholar
  5. 5.
    Hoshino (T.), Nagashima (T.), Murovic (J.A.), et al.: In situ cell kinetics studies on human neuroectodermal tumors using bromodeoxyuridine. J. Neurosurg. 64: 453–459, 1986.PubMedCrossRefGoogle Scholar
  6. 6.
    Nagashima (T.), Armond (S.J. de), Murovic (J.) et al.: Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol 67: 155–159, 1985.PubMedCrossRefGoogle Scholar
  7. 7.
    Nagashima (T.), Murovic (J.A.), Hoshino (T.) et al.: The proliferative potential of human pituitary tumors in situ. J. Neurosurg. 64: 588–593, 1986.PubMedCrossRefGoogle Scholar
  8. 8.
    Jaaskelainin (J.), Haltia (M.), Laasonen (E.), et al.: The growth rate of intracranial meningiomas and its relation to histology. Surg. Neurol. 24: 165–271, 1985.CrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Dordrecht 1987

Authors and Affiliations

  • K. G. Cho
    • 1
  • T. Hoshino
    • 1
  • T. Nagashima
    • 1
  • R. L. Davis
    • 2
  1. 1.Brain Tumor Research Center, Department of Neurological SurgeryUniversity of California, San FranciscoSan FranciscoUSA
  2. 2.Department of Neuropathology, School of MedicineUniversity of California, San FranciscoSan FranciscoUSA

Personalised recommendations